Avinger Inc
NASDAQ:AVGR

Watchlist Manager
Avinger Inc Logo
Avinger Inc
NASDAQ:AVGR
Watchlist
Price: 0.474 USD Market Closed
Market Cap: 1.6m USD

Net Margin

-239%
Current
Improving
by 10.3%
vs 3-y average of -249.3%

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-239%
=
Net Income
$-17.4m
/
Revenue
$7.3m

Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.

Net Margin
-239%
=
Net Income
$-17.4m
/
Revenue
$7.3m

Peer Comparison

Country Company Market Cap Net
Margin
US
Avinger Inc
NASDAQ:AVGR
1.6m USD
Loading...
US
Abbott Laboratories
NYSE:ABT
211.7B USD
Loading...
US
Intuitive Surgical Inc
NASDAQ:ISRG
191.8B USD
Loading...
US
Stryker Corp
NYSE:SYK
139.1B USD
Loading...
US
Boston Scientific Corp
NYSE:BSX
130.5B USD
Loading...
IE
Medtronic PLC
NYSE:MDT
124B USD
Loading...
US
Becton Dickinson and Co
NYSE:BDX
59.1B USD
Loading...
DE
Siemens Healthineers AG
XETRA:SHL
49.5B EUR
Loading...
US
IDEXX Laboratories Inc
NASDAQ:IDXX
57.2B USD
Loading...
US
Edwards Lifesciences Corp
NYSE:EW
49B USD
Loading...
US
Resmed Inc
NYSE:RMD
37.6B USD
Loading...
No Stocks Found

Market Distribution

Lower than 89% of companies in the United States of America
Percentile
11th
Based on 15 072 companies
11th percentile
-239%
Low
-4 418 600% — -9.6%
Typical Range
-9.6% — 11.3%
High
11.3% — 1 135 400%
Distribution Statistics
the United States of America
Min -4 418 600%
30th Percentile -9.6%
Median 3.1%
70th Percentile 11.3%
Max 1 135 400%

Avinger Inc
Glance View

Market Cap
1.6m USD
Industry
Health Care

Avinger, Inc. is a commercial-stage medical device company, which engages in the designs, manufactures and sells image-guided, catheter-based systems that are used by physicians to treat patients with peripheral artery disease. The company is headquartered in Redwood City, California and currently employs 74 full-time employees. The company went IPO on 2015-01-30. The firm designs, manufactures, and sells real-time, image-guided, minimally invasive catheter-based systems that are used by physicians to treat patients with peripheral artery disease (PAD). Its image-guided Lumivascular platform includes the Lightbox real-time imaging console, the Ocelot family of catheters, which are image-guided catheters designed to allow physicians to penetrate a total blockage in an artery, known as a chronic total occlusion (CTO), and the Pantheris family of catheters, its image-guided atherectomy family of catheters designed to allow physicians to remove arterial plaque in PAD patients. Its Pantheris is a single-use product and provides physicians with the ability to see a cross-sectional view of the peripheral artery to guide the removal of blockages throughout the procedure. The company has also developed a line extension of its Pantheris image-guided atherectomy platform, Pantheris SV (Small Vessel).

AVGR Intrinsic Value
Not Available
What is Net Margin?
Net Margin shows how much profit a company keeps from each dollar of sales after all expenses, including taxes and interest. It reflects the company`s overall profitability.
How is Net Margin calculated?

Net Margin is calculated by dividing the Net Income by the Revenue.

Net Margin
-239%
=
Net Income
$-17.4m
/
Revenue
$7.3m
What is Avinger Inc's current Net Margin?

The current Net Margin for Avinger Inc is -239%, which is above its 3-year median of -249.3%.

How has Net Margin changed over time?

Over the last 3 years, Avinger Inc’s Net Margin has decreased from -202.3% to -239%. During this period, it reached a low of -329.4% on Dec 31, 2022 and a high of -202.3% on Aug 30, 2021.

Back to Top